✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹42 Cr.
P/E
20.69

Key Ratios

Market cap
Market cap
42.00 Cr
PE
PE
20.69
Prom Holding
Prom Holding
48.03 %
ROE (%)
ROE (%)
9.82
ROCE (%)
ROCE (%)
21.24
Div Yield (%)
Div Yield (%)
-
Sales
Sales
121 Cr
OPM (%)
OPM (%)
3.68 %
Debt to Equity
Debt to Equity
1.66

About

Roopa Industries Ltd manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, … Read more
Low
47
52W Range
High
115
  • Roopa Industries
  • JFL Life Sciences
  • ANG Lifesciences

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Roopa Industries Ltd. Business

Roopa Industries Ltd is a manufacturer and exporter of Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids, and Water Treatment Chemicals. They also produce Neutraceuticals, Fine Chemicals, Drug Intermediates, and Bulk Drugs.

Roopa Industries major competitors are JFL Life Sciences, ANG Lifesciences, Medistep Healthcare, Kabra Drugs, Sandu Pharmaceutical, iStreet Network, Bandaram Pharma Pack.
Market Cap of Roopa Industries is ₹42 Crs.
While the median market cap of its peers are ₹44 Crs.

Roopa Industries seems to be less financially stable compared to its competitors.
Altman Z score of Roopa Industries is 2.01 and is ranked 4 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material